MedTrace Logo

Injection of Subcutaneous Glucose 10% in Small Shots is Effective in the Treatment of Diabetic Neuropathic Pain

NCT04097691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-05-07

No results posted yet for this study

Summary

Observational cohort prospective study with the following of 100 patients of type 1 and type 2 diabetes mellitus in 2 groups each group 50 patients, each group 30 males, and 20 females,35 patients with type 2 diabetes and 15 patients type 1 diabetes all have diabetic peripheral neuropathy, the second group is considered as control.

Conditions

  • Painful Diabetic Neuropathy

Interventions

DRUG

GLUCOSE 10%

subcutaneous glucose 0.5 ml per site around subcutaneous nerves

Sponsors & Collaborators

  • Ministry of Health and Population, Egypt

    lead OTHER_GOV

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-14
Primary Completion
2019-10-09
Completion
2019-10-09
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097691 on ClinicalTrials.gov